Vnitr Lek 2005, 51(1):66-70

Hypertension as a part of metabolic syndrome

H. Němcová
II. interní klinika Lékařské fakulty MU a FN u sv. Anny, Brno, přednosta doc. MUDr. Miroslav Souček, CSc.

Metabolic syndrome is a set of symptoms and diseases the integrating factor of whose is decreased tissue insulin sensitivity. Its consequences are still more important and they are prognostically serious since they relate to the diseases with mass occurence, as obesity, hypertension, diabetes, hyperlipoproteinemy. Increased insulin level as a consequence of insulinresistance leads to the weight, blood pressure and aterogenous lipids increase, significantly accelerating aterosclerosis, which is the main death cause. Therefore early detection of metabolic syndrome before the development of organ complications is necessary as well as introduction of the preventive and therapeutical measures that would decrease the cardiovascular risk as much as possible. In hypertension it means its early detection and complex effective treatment to reach both optimal blood pressure values at the concrete individual and the influence of present metabolic abnormalities. Lifestyle modification is necessary because the environmental factors significantly influence the extent to which the genetic predisposition will be exerted at last.

Keywords: metabolic syndrome; insulin resistance; hypertension; diabetes mellitus; prevention; lifestyle modification; pharmacotherapy

Received: March 15, 2004; Accepted: July 14, 2004; Published: January 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Němcová H. Hypertension as a part of metabolic syndrome. Vnitr Lek. 2005;51(1):66-70.
Download citation

References

  1. Dvořák I, Blaha M et al. Odhad rizika hypertenze u osob s normálním krevním tlakem s rodinnou zátěží. Vnitř Lék 1984; 30: 324-330. Go to PubMed...
  2. Kisters K, Tokmak F et al. Role of the Na+/Mg2+ exchanger in hypertension. Amer J Hypertens 2003; 1(16): 95-96. Go to original source... Go to PubMed...
  3. Kjeldsen SE, Rosstrup M et al. The sympatic nervous system may modulate the metabolic cardiovascular syndrom in essential hypertension. J Cardiovasc Pharmacol 1992; 20 (Suppl 8). Go to original source...
  4. Landsberg L. Insulin mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens 2001; 19: 523-528. Go to original source... Go to PubMed...
  5. Modan M, Halkin H et al. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 1985; 75: 809-817. Go to original source... Go to PubMed...
  6. Němcová H, Dvořák I et al. Změny krevního tlaku u lehkých forem hypertenze po dlouhodobém tělesném tréninku. Vnitř Lék 1989; 35(1): 30-35. Go to PubMed...
  7. Perušičová J, Anděl M, Hořejší J. Diabetes mellitus a poruchy metabolizmu lipidů. Praha: Galén 2000.
  8. Reaven G. Insulin resistance, Hypertension, and Coronary heart Disease. J Clin Hypertension 2003; 4: 269-274. Go to original source... Go to PubMed...
  9. Rosolová H. Arteriální hypertenze a diabetes mellitus. In: Perušičová J (ed). Trendy soudobé diabetologie. Praha: Galén 1999; 3. vol.
  10. Svačina Š, Owen K. Syndrom inzulínové rezistence. Praha: Triton 2003.
  11. Tsuda K. Hyperinsulinemia, intracelullar calcium, and membrane function in essential hypertension. Amer J Hypert 2003; 16(1): 19-21. Go to original source... Go to PubMed...
  12. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease. Am J Clin Nutr 1956; 4: 20-34. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.